• 검색 결과가 없습니다.

Clinical Use of Roflumilast in Chronic Obstructive Pulmonary Disease

N/A
N/A
Protected

Academic year: 2021

Share "Clinical Use of Roflumilast in Chronic Obstructive Pulmonary Disease"

Copied!
10
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

Table 2 . Treatment tolerability
Table 4. Effectiveness analysis within groups, comparing number of events during the previous year to number of events in the 1 year of follow-up

참조

관련 문서

Keywords: Trabecular bone score, End stage renal disease, Hemodialysis, Chronic kidney disease-mineral and bone disorder, Fracture, Cardiovascular

1) Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. Yates, B.S., Jørgen Vestbo, M.D.,

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind,

GRIPHON Prostacyclin (PGI2) Receptor Agonist In Pulmonary Arterial Hypertension IPAH idiopathic pulmonary arterial hypertension MCTD mixed connective tissue

Severe disease activity and cy- tomegalovirus colitis are predictive of a nonresponse to infliximab in patients with ulcerative colitis. Guidelines for the management of

19) Yu Y, Kang J., Clinical studies on treatment of chronic prostatitis with acupuncture

Approved clinical use of bone marrow stem cells for myocardial infarction treatment... Cardiac

Background : Janus tyrosine kinase 2 (JAK2) V617F mutation has been described in a high proportion of patients with Philadelphia